Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.280
-0.030 (-1.30%)
May 8, 2026, 3:22 PM EDT - Market open
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $411.21 million as of May 8, 2026. Its market cap has increased by 783.83% in one year.
Market Cap
411.21M
Enterprise Value
345.77M
1-Year Change
783.83%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $411.21M, a decrease of -60.87%. That is a compound annual growth rate of -17.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 416.62M | 379.65% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 436.47M |
| Avalo Therapeutics | 434.38M |
| Enanta Pharmaceuticals | 420.20M |
| Neumora Therapeutics | 420.18M |
| Benitec Biopharma | 418.94M |
| Larimar Therapeutics | 416.57M |
| PureTech Health | 416.06M |
| vTv Therapeutics | 394.62M |